123 related articles for article (PubMed ID: 1469452)
21. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022.
Trejaut J; Bhatia K; Greville WD; Hu KR; Duraisamy G; Nuchprayoon C; Donald J; Aziz A; Dunckley H
Eur J Immunogenet; 1996 Dec; 23(6):437-49. PubMed ID: 8971541
[TBL] [Abstract][Full Text] [Related]
22. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy.
Honda Y; Juji T; Matsuki K; Naohara T; Satake M; Inoko H; Someya T; Harada S; Doi Y
Sleep; 1986; 9(1 Pt 2):133-42. PubMed ID: 3010426
[TBL] [Abstract][Full Text] [Related]
23. HLA DR2 in narcolepsy with sleep-onset REM periods but not cataplexy.
Rosenthal L; Roehrs TA; Hayashi H; Zorick FJ; Wittig RM; Rosenthal J; Roth T
Biol Psychiatry; 1991 Oct; 30(8):830-6. PubMed ID: 1751625
[TBL] [Abstract][Full Text] [Related]
24. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.
Mignot E; Lin X; Arrigoni J; Macaubas C; Olive F; Hallmayer J; Underhill P; Guilleminault C; Dement WC; Grumet FC
Sleep; 1994 Dec; 17(8 Suppl):S60-7. PubMed ID: 7701202
[TBL] [Abstract][Full Text] [Related]
25. Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients.
Zeliszewski D; Tiercy JM; Boitard C; Gu XF; Loche M; Krishnamoorthy R; Simonney N; Elion J; Bach JF; Mach B
Hum Immunol; 1992 Feb; 33(2):140-7. PubMed ID: 1348743
[TBL] [Abstract][Full Text] [Related]
26. MHC class II sequences of an HLA-DR2 narcoleptic.
Lock CB; So AK; Welsh KI; Parkes JD; Trowsdale J
Immunogenetics; 1988; 27(6):449-55. PubMed ID: 3259543
[TBL] [Abstract][Full Text] [Related]
27. HLA-DR2 and narcolepsy: not all narcoleptic-cataplectic patients are DR2.
Guilleminault C; Grumet C
Hum Immunol; 1986 Sep; 17(1):1-2. PubMed ID: 3488983
[No Abstract] [Full Text] [Related]
28. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
29. Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC).
De La Concha EG; Fernandez-Arquero M; Santa-Cruz S; Lopez-Nava G; Figueredo MA; Diaz-Rubio M; Garcia-Paredes J
Clin Exp Immunol; 1997 Jun; 108(3):392-5. PubMed ID: 9182881
[TBL] [Abstract][Full Text] [Related]
30. HLA class II analysis in Jewish Israeli narcoleptic patients.
Kwon OJ; Peled N; Miller K; Pillar G; Peled R; Lavie P; Brautbar C; Amar A
Hum Immunol; 1995 Dec; 44(4):199-202. PubMed ID: 8770632
[TBL] [Abstract][Full Text] [Related]
31. Full-length DQ beta cDNA sequences of HLA-DR2/DQw1 subtypes: genetic interactions between two DQ beta loci generate human class II HLA diversity.
Wu SK; Lu D; Madden M; Liu CP; Miyokawa N; Bach FH; Saunders TL
Hum Immunol; 1990 Apr; 27(4):305-22. PubMed ID: 2318676
[TBL] [Abstract][Full Text] [Related]
32. HLA-DR restriction-fragment-length polymorphisms in narcolepsy.
Holloman JD; Bell JI; Kilduff TS; Dement WC; Guilleminault C; McDevitt HO
J Neurosci Res; 1987; 18(1):239-44. PubMed ID: 2890770
[TBL] [Abstract][Full Text] [Related]
33. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis.
Serjeantson SW; Gao X; Hawkins BR; Higgins DA; Yu YL
Eur J Immunogenet; 1992; 19(1-2):11-9. PubMed ID: 1567812
[TBL] [Abstract][Full Text] [Related]
34. DRB1*1502-DQB1*0601-DQA1*0103 and DRB1*04-DQB1*0302 in Jewish hypersomnolent patients.
Peled N; Amar A; Peled E; Brautbar C; Pillar G
Sleep Med; 2002 May; 3(3):267-70. PubMed ID: 14592217
[TBL] [Abstract][Full Text] [Related]
35. A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility.
Carcassi C; Trucco G; Trucco M; Contu L
Hum Immunol; 1991 Jul; 31(3):159-64. PubMed ID: 1890017
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic criteria for narcolepsy and HLA-DR2 frequencies.
Matsuki K; Honda Y; Juji T
Tissue Antigens; 1987 Oct; 30(4):155-60. PubMed ID: 3120349
[TBL] [Abstract][Full Text] [Related]
37. [Post-traumatic narcolepsy with negative HLA DR2 and DQW1. Study of one case].
RodrÃguez Campello A; Roquer J; Palomeras E; Munteis E
Neurologia; 1999; 14(7):367-8. PubMed ID: 10570627
[No Abstract] [Full Text] [Related]
38. Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject.
Onofrj M; Curatola L; Ferracci F; Fulgente T
J Neurol Neurosurg Psychiatry; 1992 Sep; 55(9):852-3. PubMed ID: 1402982
[TBL] [Abstract][Full Text] [Related]
39. HLA-DR2 and narcolepsy.
Billiard M; Seignalet J; Besset A; Cadilhac J
Sleep; 1986; 9(1 Pt 2):149-52. PubMed ID: 3486442
[TBL] [Abstract][Full Text] [Related]
40. No association between HLA-DR2 and the sudden infant death syndrome.
Kaada B; Spurkland A
Acta Paediatr; 1992 Mar; 81(3):283. PubMed ID: 1511209
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
